Parkwalk Advisors
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Brainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis
Brainomix develops medical imaging software that helps clinicians assess stroke and lung fibrosis using automated image analysis. Its platforms support diagnosis and treatment decisions by analysing scans and providing clinical insights at the point of care.
xWatts lands a £1.6m seed round led by Cambridge Enterprise Ventures to decarbonise complex real estate
xWatts builds an energy management platform that connects to building systems and optimises performance in real time. It helps complex estates reduce energy consumption and carbon emissions through automated control.
Scripta Therapeutics raises £9m seed led by Oxford Science Enterprises and Apollo Health Ventures to upend conventional drug discovery
Scripta Therapeutics applies AI and experimental biology to map disease-driving transcription networks, aiming to identify new drug targets for neurodegenerative and complex conditions.
NoBACZ Healthcare raises £4.8m led by The Yield Lab to expand liquid bandage technology for livestock and horses
NoBACZ Healthcare develops antibiotic-free liquid bandage technology for livestock and horses, creating protective wound coatings that reduce infection risk in agricultural environments.
Trismik secures £2.2m pre-seed led by Twin Path Ventures to launch tools for designing and analysing LLM experiments
Trismik provides tools for evaluating large language models using adaptive testing, helping AI teams measure capability, safety and reasoning more accurately while reducing the cost and time of traditional benchmarking.
Enhanced Genomics raises £14m Series A from investors to advance therapeutics pipeline with its 3D multi-omics platform
Enhanced Genomics uses a three-dimensional multi-omics platform to identify genetically validated drug targets, supporting the development of new medicines for complex common diseases.
Phasecraft raises £25m Series B led by Plural, Playground Global and Novo Holdings to help quantum computing solve real-world challenges
Phasecraft develops hardware-agnostic quantum algorithms that allow today’s quantum computers to solve practical problems, supporting applications in materials science, energy optimisation and industrial research without waiting for perfect hardware.
Bitfount raises £6m Series A led by Parkwalk to scale privacy-preserving AI for clinical trials
Bitfount provides federated AI infrastructure for clinical research, allowing hospitals and pharmaceutical companies to collaborate on trials and analysis without sharing sensitive patient data.
Brainomix completes £14m Series C led by Parkwalk Advisors to advance AI imaging technology in healthcare
Brainomix develops AI-powered medical imaging software for stroke and lung disease, helping clinicians diagnose conditions faster and make better treatment decisions using automated biomarkers.
Cambridge GaN Devices raises £25m in Series C funding to scale energy-efficient semiconductor technology
Cambridge GaN Devices designs gallium nitride power devices that improve energy efficiency and performance in electric vehicles, data centres and industrial systems by enabling faster switching and lower energy losses.
PervasID raises £3.25m led by Parkwalk Advisors to enhance world-leading RFID tracking technology
PervasID develops high-accuracy RFID tracking systems that enable organisations to identify and monitor tagged items over long ranges, supporting inventory visibility and operational efficiency in sectors such as retail and aerospace.
AI-powered autonomous testing platform Diffblue secures £5m amidst rapid growth
Diffblue develops generative AI software that autonomously writes tests for Java code, helping engineering teams improve coverage, reliability and productivity without manual effort.
More venture news
- 24 Feb 2026
BrainomixBrainomix lands a £4.8m Series C extension led by Parkwalk Advisors and Hostplus for AI medical imaging in stroke and lung fibrosis
ExtensionHealth - 24 Feb 2026
Centauri TherapeuticsCentauri Therapeutics secures a £6m Series A extension from AMR Action Fund to target drug-resistant bacterial infections with immunotherapy
ExtensionLife Sciences - 17 Feb 2026
SurrealDB secures a £17m Series A extension led by Chalfen Ventures and Begin Capital for its multi-model database for AI
ExtensionEnterprise
